Late Stage IV, a Series of Carya Funds, LLC

The three named GPs—Corporation Alternative Financial, Bryan Casey, and LLC Carya Management—indicate a hybrid structure where an institutional entity (Corporation Alternative Financial) shares decision-making with named individual GP (Casey) alongside the management company, a pattern typical of managers who transitioned from independent practice into a fund management infrastructure rather than organic team build-out.

Filing in June 2026 aligns with LP capital allocation cycles that reset in Q2, when institutions finalize FY deployment budgets and emerging-manager allocations; late-stage venture specifically benefits from mid-year fundraising when Series C-D+ companies have fresh valuations and LPs are reassessing their venture exposure after H1 2026 performance reviews.

Before commitment, verify whether Bryan Casey holds a key-person clause tied to fund operations and LP distributions—the prominence of a named individual GP in a three-person structure suggests concentration risk if his involvement is contractually material, and confirm via side letter what happens to decision-making or fees if he exits.